NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,930
+170 (1.15%)
Jun 20, 2025, 3:30 PM KST

NeoPharm CO., LTD. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
122,407119,01497,10585,03387,93181,625
Upgrade
Other Revenue
0---0--
Upgrade
Revenue
122,407119,01497,10585,03387,93181,625
Upgrade
Revenue Growth (YoY)
20.32%22.56%14.20%-3.29%7.72%-1.94%
Upgrade
Cost of Revenue
44,91644,98731,72026,65325,54422,984
Upgrade
Gross Profit
77,49174,02765,38558,38062,38658,642
Upgrade
Selling, General & Admin
46,72944,25936,27632,98436,02232,991
Upgrade
Research & Development
3,4163,4072,6472,8542,9352,802
Upgrade
Operating Expenses
51,84949,37440,07836,94139,95536,740
Upgrade
Operating Income
25,64224,65325,30721,43922,43121,902
Upgrade
Interest Expense
-36.89-40.78-21.32-8.84-38.46-56.37
Upgrade
Interest & Investment Income
4,1354,1554,5882,0771,1771,366
Upgrade
Currency Exchange Gain (Loss)
1,8892,006-117.74205.38662.9-126.04
Upgrade
Other Non Operating Income (Expenses)
-279.98-795.4-362.95-376.73-430.38-138.91
Upgrade
EBT Excluding Unusual Items
31,35029,97829,39323,33523,80122,947
Upgrade
Gain (Loss) on Sale of Investments
251.15251.15-2.76-48.48-
Upgrade
Gain (Loss) on Sale of Assets
-26.45-17.17-3.7-6.05-3.23-10.81
Upgrade
Asset Writedown
-3.21-3.3-13.47-6.23-11.07-
Upgrade
Pretax Income
31,57130,20929,37323,32323,83622,936
Upgrade
Income Tax Expense
7,4827,1446,1606,2966,1224,805
Upgrade
Net Income
24,09023,06523,21317,02717,71318,131
Upgrade
Net Income to Common
24,09023,06523,21317,02717,71318,131
Upgrade
Net Income Growth
6.99%-0.64%36.33%-3.87%-2.30%-5.79%
Upgrade
Shares Outstanding (Basic)
161616161616
Upgrade
Shares Outstanding (Diluted)
161616161616
Upgrade
Shares Change (YoY)
-----0.95%4.38%
Upgrade
EPS (Basic)
1540.131474.611484.071088.601132.471159.17
Upgrade
EPS (Diluted)
1540.001474.611484.001088.501132.471148.00
Upgrade
EPS Growth
6.98%-0.63%36.33%-3.88%-1.35%-9.75%
Upgrade
Free Cash Flow
23,37515,8323,41117,70721,36116,788
Upgrade
Free Cash Flow Per Share
1494.441012.16218.061132.041365.691063.18
Upgrade
Dividend Per Share
600.000600.000375.000350.000350.000325.000
Upgrade
Dividend Growth
60.00%60.00%7.14%-7.69%-13.33%
Upgrade
Gross Margin
63.31%62.20%67.33%68.66%70.95%71.84%
Upgrade
Operating Margin
20.95%20.71%26.06%25.21%25.51%26.83%
Upgrade
Profit Margin
19.68%19.38%23.91%20.02%20.14%22.21%
Upgrade
Free Cash Flow Margin
19.10%13.30%3.51%20.82%24.29%20.57%
Upgrade
EBITDA
28,83127,80326,98023,05523,93123,396
Upgrade
EBITDA Margin
23.55%23.36%27.79%27.11%27.22%28.66%
Upgrade
D&A For EBITDA
3,1893,1501,6731,6161,5001,494
Upgrade
EBIT
25,64224,65325,30721,43922,43121,902
Upgrade
EBIT Margin
20.95%20.71%26.06%25.21%25.51%26.83%
Upgrade
Effective Tax Rate
23.70%23.65%20.97%27.00%25.69%20.95%
Upgrade
Advertising Expenses
-13,56312,40811,53314,69512,686
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.